Healthcare & life sciences
The governing constraint is that patient data must not be on a shared ledger, which rules out most of what this sector is pitched. What remains is real: consent, provenance of a sample or a batch, and audit trails over decisions that affect a patient without containing the patient.
Where we are usually engaged
Consent and access records
Who consented to what, when, and the revocation that has to propagate.
Batch and sample provenance
Chain of custody for a physical item, with the identity data held off the shared record.
Decision evidence for clinical AI
Which inputs a system saw, which policy applied, and who could have overridden it.
The question we ask first
Can this system meet its objective while holding no personal data on the shared record?
If it cannot, our recommendation will be against the ledger. That has been the outcome more than once.
Capabilities in this sector
- AI transformationcapability page
Related engagements
- Settlement infrastructure for a gold-backed monetary system, with daily close against a custodial reserve.re-permission pending
- Protocol-side engineering engagement.re-permission pending
- Credit data system built on a public ledger.re-permission pending
Listings subject to client permission.
The capital-side coverage of this sector: Healthcare & Life Sciences on gda.group.
Reference reading
Start a conversation
Tell us what you are trying to build in healthcare & life sciences, and what has to be true for it to work.